BioZorb Lawsuit News:
New Scheduling Orders & Bellwether Preparation
Hundreds of women who suffered complications from BioZorb implants are now pursuing claims against Hologic. Bellwether cases are already moving under coordinated scheduling orders — MDL formation is expected. Our firm is accepting cases nationwide.
Where the Cases Stand
BioZorb Litigation: Key Developments
Although no formal MDL has been created yet, BioZorb litigation is already functioning like a mass tort. Coordinated scheduling orders, standardized discovery, and synchronized bellwether preparation are all underway across multiple federal districts.
Surge
Litigation accelerates sharply as evidence of widespread device failure becomes public. Hundreds of cases filed across state and federal courts.
2025
A unified Scheduling Order sets deadlines for fact discovery, expert disclosures, and bellwether selection across early cases — including Taylor, Deuel, Kresch, and Gibson.
2026
Multiple federal cases advance under coordinated scheduling. The JPML is actively considering centralization into a numbered BioZorb MDL.
2026+
Once the JPML rules, expect a numbered MDL with coordinated discovery and a formal bellwether trial program that will shape settlement values.
What Plaintiffs Allege
How BioZorb Failed Patients
Plaintiffs allege that Hologic’s BioZorb marker was defectively designed and that the company failed to adequately warn surgeons and patients of known risks. Reports of device failure have included some of the most serious complications possible from a surgical implant.
Failed to Absorb
Despite being marketed as fully absorbable, the device persisted in patients’ bodies, causing ongoing inflammation, fibrosis, and chronic pain.
Device Migration
Reports of the BioZorb marker shifting position within the breast, complicating radiation delivery and causing additional injury.
Extrusion & Skin Erosion
In severe cases, the device extruded through the skin, requiring emergency surgical intervention and leaving permanent scarring.
Disfigurement & Nerve Damage
Patients suffered permanent cosmetic deformity and nerve damage — injuries they were not warned about before surgery.
Radiation Complications
Device failure interfered with radiation therapy guidance — the device’s core purpose — potentially compromising cancer treatment outcomes.
Inadequate Warning
Plaintiffs allege Hologic knew of these risks and failed to disclose them to surgeons or patients before implantation.
Eligibility
Common Injuries Linked to BioZorb
You may qualify if you received a BioZorb implant following breast-conserving surgery and subsequently experienced any of the following complications.
Qualifying Injuries
- Chronic breast pain
- Infection or abscess
- Device migration
- Skin erosion or extrusion
- Disfigurement or permanent scarring
- Need for revision or removal surgery
- Radiation therapy complications
General Eligibility Factors
- Received a BioZorb implant after breast-conserving surgery (lumpectomy)
- Experienced one or more qualifying complications
- Complication documented in medical records
- Manufactured by Hologic, Inc.
Our Firm Is Now Accepting BioZorb Cases
We represent women nationwide who suffered complications from BioZorb implants. Our team investigates medical records, surgical reports, and device failures to build the strongest possible case — and we track every development in pre-MDL scheduling, bellwether preparation, and emerging settlement discussions.
We work on a contingency fee basis — you pay nothing unless we win.